Page 3 - America Ph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hearing set to consider penalties for pharmaceutical company over Arkansas law | Northwest Arkansas Democrat-Gazette

A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 the 340B Drug Pricing Nondiscrimination Act.

United statesWest virginiaAmerica phJudd semingsonAlan mcclainBilly roy wilsonExelixis pharmaceuticalsCommunity clinicHealth resources services administrationB drug pricing programArkansas insurance departmentB drug program nondiscrimination requirementsUs supreme courtJazz pharmaceuticals incyteMerck co incyteAstrazeneca pharmaceuticals

Hearing set to consider penalties for pharmaceutical company over Arkansas law | The Arkansas Democrat-Gazette

A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 the 340B Drug Pricing Nondiscrimination Act.

West virginiaUnited statesAlan mcclainAmerica phJudd semingsonBilly roy wilsonMerck coMerck co incyteJazz pharmaceuticals incyteHealth resources services administrationB drug program nondiscrimination requirementsArkansas insurance departmentB drug pricing programUnion chimique belgeCircuit courtCommunity clinic

Expansion to FTC s Orange Book Campaign Leads to Calls for More Clarity from Pharmaceutical Industry

On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper patent listings in the U.S. Food & Drug Administration’s (FDA) Orange Book.

United statesTudorza pressairHans sauerAirduo respiclickBreo elliptaTrelegy elliptaArmonair respiclickMegan van ettenIncruse elliptaAirduo digihalerCovis pharma gmbAmerica phArmonair digihalerRobertm califfNorton waterfordStiolto respimat

Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB

Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

America phRichardd connellJohn crowleyTakeda pharmaceuticalsBiotechnology innovation organizationWuxi apptecPharmaceutical researchInflation reduction

Takeda leaves industry trade group BIO (NYSE:TAK)

Takeda leaves industry trade group BIO (NYSE:TAK)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

America phJohn crowleyBiotechnology innovation organizationAmicus therapeuticsTakeda pharmaceutical companyTakeda pharmaceuticalStat newsFiscal yearPharmaceutical research